L. Brenton Saunders's most recent trade in Bausch + Lomb Corp was a trade of 4,231 Common Shares, No Par Value done at an average price of $14.4 . Disclosure was reported to the exchange on Aug. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bausch + Lomb Corp | Brenton L. Saunders | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.44 per share. | 05 Aug 2025 | 4,231 | 736,925 | - | 14.4 | 61,096 | Common Shares, No Par Value |
| Bausch + Lomb Corp | Brenton L. Saunders | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2025 | 150,000 | 900,000 | - | - | Performance Stock Units | |
| ARS Pharmaceuticals Inc | Brenton L. Saunders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2025 | 73,051 | 5,994,820 | - | - | Class A Common Stock | |
| Bausch + Lomb Corp | Brenton L. Saunders | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 22,000 | 741,156 | - | 0 | Common Shares, No Par Value | |
| Bausch + Lomb Corp | Brenton L. Saunders | Director, CEO and Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 11.28 per share. | 22 May 2025 | 22,000 | 719,156 | - | 11.3 | 248,072 | Common Shares, No Par Value |
| ARS Pharmaceuticals Inc | Brenton L. Saunders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2025 | 120,000 | 470,950 | - | - | Stock Option (Right to Buy) | |
| ARS Pharmaceuticals Inc | Brenton L. Saunders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 20 May 2025 | 120,000 | 120,000 | - | 1.0 | 121,200 | Common Stock |
| ARS Pharmaceuticals Inc | Brenton L. Saunders | Director | Sale of securities on an exchange or to another person at price $ 14.25 per share. | 20 May 2025 | 120,000 | 0 | - | 14.3 | 1,710,024 | Common Stock |
| Bausch + Lomb Corp | Brenton L. Saunders | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 600,858 | 600,858 | - | - | Non-Qualified Stock Options (right to purchase) | |
| Bausch + Lomb Corp | Brenton L. Saunders | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 168,168 | 697,156 | - | 0 | Common Shares, No Par Value | |
| Bausch + Lomb Corp | Saunders L. Brenton | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.83 per share. | 23 Dec 2024 | 73,782 | 553,637 | - | 17.8 | 1,315,533 | Common Shares, No Par Value |
| Bausch + Lomb Corp | Saunders Brenton L. | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.83 per share. | 23 Dec 2024 | 24,649 | 528,988 | - | 17.8 | 439,492 | Common Shares, No Par Value |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Chairman | Purchase of securities on an exchange or from another person at price $ 1.08 per share. | 12 Aug 2024 | 40,450 | 5,921,769 | - | 1.1 | 43,686 | Class A Common Stock |
| Bausch + Lomb Corp | Brenton L. Saunders | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 32,250 | 627,419 | - | 0 | Common Shares, No Par Value | |
| Bausch + Lomb Corp | Brenton L. Saunders | Director, CEO and Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 15.66 per share. | 05 Aug 2024 | 32,250 | 595,169 | - | 15.7 | 505,067 | Common Shares, No Par Value |
| ARS Pharmaceuticals Inc | Brenton L. Saunders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Bausch + Lomb Corp | Saunders Brenton L. | Director, CEO and Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 569,105 | 569,105 | - | - | Non-Qualified Stock Options (right to purchase) | |
| Bausch + Lomb Corp | L. Brenton Saunders | Director, CEO and Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 187,919 | 562,919 | - | 0 | Common Shares, No Par Value | |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Chairman | Purchase of securities on an exchange or from another person at price $ 6.10 per share. | 16 Aug 2023 | 59,380 | 5,827,453 | - | 6.1 | 362,372 | Class A Common Stock |
| ARS Pharmaceuticals Inc | Brenton L. Saunders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 16,357 | 5,768,073 | - | - | Class A Common Stock | |
| Cisco | Brenton L. Saunders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2022 | 5,001 | 24,143 (0%) | 0% | 0 | Common Stock | |
| ARS Pharmaceuticals Inc | Brenton L. Saunders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 590,950 | 590,950 | - | - | Stock option (right to buy) | |
| ARS Pharmaceuticals Inc | Brenton L. Saunders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 153,647 | 153,647 | - | - | Stock option (right to buy) | |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 78,534 | 5,881,319 | - | - | Class A Common Stock | |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.90 per share. | 31 Mar 2022 | 13,548 | 5,802,785 | - | 12.9 | 174,769 | Class A Common Stock |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.88 per share. | 31 Mar 2022 | 3,711 | 5,823,742 | - | 16.9 | 62,642 | Class A Common Stock |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.86 per share. | 31 Mar 2022 | 3,076 | 5,820,666 | - | 12.9 | 39,557 | Class A Common Stock |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.10 per share. | 31 Mar 2022 | 2,167 | 5,816,333 | - | 9.1 | 19,720 | Class A Common Stock |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.79 per share. | 31 Mar 2022 | 2,166 | 5,818,500 | - | 11.8 | 25,537 | Class A Common Stock |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 158,450 | 5,751,716 | - | - | Class A Common Stock | |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 35,581 | 5,593,266 | - | - | Class A Common Stock | |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.24 per share. | 27 Jan 2022 | 6,812 | 5,557,685 | - | 12.2 | 83,379 | Class A Common Stock |
| Cisco | Brenton L. Saunders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2021 | 4,180 | 32,503 (0%) | 0% | 0 | Common Stock | |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 60,000 | 60,000 | - | - | Performance Restricted Stock Units | |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 30,963 | 5,564,497 | - | 0 | Class A Common Stock | |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Ten Percent Owner, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 14 May 2021 | 11,500,000 | 0 | - | 0 | Class A Common Stock | |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Ten Percent Owner, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 14 May 2021 | 9,333,333 | 0 | - | - | Warrant (right to buy) | |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2021 | 11,500,000 | 0 | - | - | Class B Common Stock | |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2021 | 11,500,000 | 11,500,000 | - | 0 | Class A Common Stock | |
| Beauty Health Company (The... | Brenton L. Saunders | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,860,000 | 1,860,000 | - | - | Stock Options (right to buy) | |
| Cisco | Brenton L. Saunders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 5,189 | 27,543 (0%) | 0% | 0 | Common Stock |